key: cord-0975447-7bf53y6s authors: Sharif-Askari, Narjes Saheb; Sharif-Askari, Fatemeh Saheb; Alabed, Mashael; Temsah, Mohamed-Hani; Alheialy, Saba; Hamid, Qutayba; Halwani, Rabih title: Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD date: 2020-05-22 journal: Mol Ther Methods Clin Dev DOI: 10.1016/j.omtm.2020.05.013 sha: 964f0e0fdd95510f1a12283d4c6972c79598abe1 doc_id: 975447 cord_uid: 7bf53y6s Abstract It has been reported that ACE2 and TMPRSS2 are the main cell entry proteins for SARS-CoV-2 and play a critical role in causing COVID-19. To investigate the expression level of these SARS-CoV-2 host cell entry genes in lung airway, public gene expression datasets were used. We have found a differential expression of ACE2 and TMPRSS2 in nasal and bronchial airways relative to age and diseases status. Children were found to have significantly lower expression of COVID-19 receptors in the upper and lower airways (nasal and bronchial). Moreover, the lung airway expression of both ACE2 and TMPRSS2 was found to be significantly upregulated in smokers compared to non-smokers; and in patients with COPD compared to healthy. No difference was observed in the blood expression levels of ACE2 and TMPRSS2 between children and adults, or in COPD or diabetic patients. However, a significant increase in blood expression levels of these genes was observed in patients with essential hypertension; while only ACE2 was upregulated in the blood of asthmatic. These results suggest that the observed difference in COVID-19 severity between children and adults could, in part, be attributed to the difference in ACE2 and TMPRSS2 airways tissue expression levels. It has been reported that ACE2 and TMPRSS2 are the main cell entry proteins for SARS-40 CoV-2 and play a critical role in causing COVID-19. To investigate the expression level of 41 these SARS-CoV-2 host cell entry genes in lung airway, public gene expression datasets 42 were used. We have found a differential expression of ACE2 and TMPRSS2 in nasal and 43 bronchial airways relative to age and diseases status. Children were found to have 44 significantly lower expression of COVID-19 receptors in the upper and lower airways (nasal 45 and bronchial). Moreover, the lung airway expression of both ACE2 and TMPRSS2 was 46 found to be significantly upregulated in smokers compared to non-smokers; and in patients 47 with COPD compared to healthy. No difference was observed in the blood expression levels 48 of ACE2 and TMPRSS2 between children and adults, or in COPD or diabetic patients. 49 However, a significant increase in blood expression levels of these genes was observed in 50 patients with essential hypertension; while only ACE2 was upregulated in the blood of 51 asthmatic. These results suggest that the observed difference in COVID-19 severity between 52 children and adults could, in part, be attributed to the difference in ACE2 and TMPRSS2 53 airways tissue expression levels . 54 55 56 57 58 59 60 61 62 63 64 Introduction 71 72 73 Over the last two decades, three waves of coronavirus outbreaks among humans has irrupted, 74 Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) 2019. The disease caused by these coronaviruses has pneumonia-like symptoms such as fever 77 and dry-cough and leads to progressive respiratory failure, and even death. 3 SARS-CoV 1 and 78 The new SARS-CoV-2 was found to share 79.6% sequence identity with SARS-CoV. 5 90 Besides, the virus uses the same cell receptor as SARS-CoV, Angiotensin Converting 91 Enzyme 2 (ACE2) to enter the cell. It was also found to need Transmembrane Serine 92 Protease 2 (TMPRSS2) for priming of the viral spike protein. 6 The level of expression of the 93 viral receptor (ACE2) and TMPRSS2, especially in the nasal tissue, may be critical for the 94 ability of the virus to transmit and replicate. 7 95 96 SARS-CoV-2 is believed to have a much higher rate of transmission compared to SARS-CoV 97 and MERS-CoV. 8 The majority of people infected were of older ages (approximate age 30-79 98 range years) and developed mild symptoms; while around 19% developed severe conditions 99 and needed critical care. 9 Many of the patients who developed critical conditions had, in fact, 100 chronic diseases such as cardiovascular diseases and diabetes. 10 Throughout the three 101 epidemics, low rate of infection was reported in infants and children with mostly a milder 102 disease profile. [11] [12] [13] The reason behind that is still a mystery. 103 104 Several theories has been discussed for why children are less susceptible to SARS-CoV-2 105 infection, 14, 15 and less prone to develop severe conditions following infection with SARS-106 CoV-2. 16 One possibility is their young immune system which could be more efficient in 107 clearing the infection compared to the adults immune system. Another possibility is the 108 presence of cross immunity due to a previous exposure to a milder widespread form of 109 corona viruses. 11, 17 However, one possibility could also be that they express lower levels of 110 the viral receptors that could limit transmission to these young population and the 111 development of severe conditions. Hence, we tested the hypothesis that the expression of 112 viral receptors, ACE2 and TMPRSS2 in children is lower than that in adults. Moreover, since 113 ACE2 is known to be regulated by hypoxia, stress, and several inflammatory mediators, 18 we 114 have also tested whether its expression increases due to smoking, and during chronic 115 inflammatory diseases, affecting the lung such as asthma, COPD, and Idiopathic pulmonary 116 fibrosis (IPF); as well as diabetes and hypertension. In this study we evaluated airway tissue gene expression levels of SARS-CoV-2 receptors, 128 ACE2 and TMPRSS2 using publicly available transcriptomic datasets of nasal and lung 129 airway tissue, as well as blood and Saliva. The list of the extracted datasets that passed the 130 quality control and were included in our analysis are presented in the Table S1 . Moreover, the expression of these two genes was found to be significantly higher in nasal 143 compared to blood or saliva of adult subjects ( Figure S2D , P<0.0001). This significant 144 differential expression of both ACE2 and TMPRSS2 between children and adults could 145 contribute to the lower infectivity and disease severity observed in younger populations. In 146 addition, the increased expression of these receptors in nasal compared to blood or saliva 147 suggest transmission could be higher through nasal compared to the oral cavity. 148 We next determined whether the expression of ACE2 and TMPRSS2 increases in lung tissue 149 in the presence of other comorbidities, especially those associated with a more severe SARS-150 CoV-2 infection. To do that, we compared the lung tissue expression levels of ACE2 and 151 TMPRSS2 in patient with comorbidities compared to healthy controls. Datasets of blood 152 (PBMCs) were used for patients with hypertension and diabetes since no transcriptomic data 153 of lung tissue was available for these groups. Upon analyzing transcriptomic datasets of lung 154 biopsies obtained from COPD adult patients, ACE2 (P= 0.003) and TMPRSS2 (P= 0.0002) 155 were both found to be significantly upregulated ( Figure 2A ). The expression of these two 156 genes was also significantly increased in lung tissue of smokers compared to healthy subject 157 ( Figure 2A ; ACE2, P= 0.002 and TMPRSS2, P <0.0001). This suggested that the observed 158 increase in the lung tissue of COPD patients could mostly be attributed to the effect of 159 smoking. No difference was observed in the blood expression levels of these genes for COPD 160 compared to healthy controls ( Figure S1A ). 161 Although there was no difference in the level of ACE2 expression in asthmatic bronchial 163 epithelial cells compared to healthy controls, the levels of TMPRSS2 (P= 0.002) was found 164 to be significantly elevated ( Figure 2B ). The same pattern was observed upon the assessment 165 of transcriptomic data obtained from the bronchial epithelial cells of asthmatic children. The 166 expression levels of ACE2 was not different compared to healthy controls but the levels of 167 TMPRSS2 (P=0.0002) were significantly higher ( Figure S2A ). This pattern of expression 168 was reversed in the blood of asthmatics, where ACE2 expression was significantly elevated 169 but no difference in the levels of TMPRSS2 was observed ( Figure S1B ). In addition, no 170 difference was observed in the expression levels of ACE2 and TMPRSS2 neither in bronchial 171 tissue of patients with idiopathic pulmonary fibrosis ( Figure 2C ), nor in lung tissue of 172 patients with sarcoidosis ( Figure S2B ) or Scleroderma-associated interstitial lung disease 173 ( Figure S2C) . 174 175 Interestingly, the levels of ACE2 and TMPRESS2 were found to be significantly elevated in 176 blood (PBMCs) of patients with hypertension compared to healthy controls ( Figure 2D , P 177 <0.0001). However, no difference in the receptors gene expression was detected in blood 178 (PBMCs) of patients with diabetes ( Figure S1C) . 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 Discussion 217 218 219 In this study, using several public gene-expression data sets, we have showed that SARS-220 CoV-2 receptor, ACE2, and TMPRSS2 are expressed at significantly higher levels in nasal 221 epithelium compared to blood and saliva; and this expression decreases significantly in lower 222 lung airway tissue. Importantly, the expression of ACE2 and TMPRSS2 in nasal tissue of 223 children is significantly lower than that of adults. Likewise, the bronchial tissue expression of 224 these genes was also lower in children compared to adults. To the best of our knowledge, this 225 is the first study to report lower ACE2 and TMPRSS2 expression in children nasal and 226 bronchial epithelial cells compared to adults. idiopathic pulmonary fibrosis, nor with sarcoidosis or scleroderma-associated interstitial lung 252 disease. In addition, no difference in the blood levels of ACE2 and TMPRSS2 expression 253 between children and adults was observed. However, a significant level in blood expression 254 of ACE2 and TMPRSS2 observed for patients with hypertension; while only ACE2 was 255 upregulated in the blood of asthmatics. This may explain the increased risk of these patients 256 for SARS-CoV-2 infection. The absence of difference in blood expression levels of patients 257 with chronic diseases such as diabetes does not exclude the possibility of increased 258 expression of these entry genes in lung tissue of these patients, however, we had no available 259 data to investigate that. It would, hence, be interesting to determine the lung expression levels 260 of SARS-CoV-2 receptors in these patients. 261 The increased expression of ACE2 and TMPRSS2 in upper respiratory tract compared to 263 blood and lower respiratory tract could contribute to the increased replication of SARS-CoV-264 2 in this tissue. Recently, Zou et al reported that SARS-CoV-2 viral load is higher in nasal 265 compared to throat swabs. 7 Based on our finding, the reason for that could be the higher 266 expression of ACE2 and TMPRSS2 in nasal compared to throat swaps. In fact, the level of 267 these genes in saliva was significantly lower than that of nasal epithelium ( Figure S2D ). 268 Interestingly, TMPRSS2 was found to be expressed in nasal and bronchial epithelial cells 269 along with ACE2. SARS-CoV-2 needs this host serine protease for spike protein priming, In this study, bioinformatic analyses was conducted to evaluate the expression levels of 298 ACE2 and TMPRSS2 gene signatures in blood, upper and lower respiratory tract tissues, and 299 saliva for children, adults. The expression was also evaluated in lung tissue of smokers and 300 patients with chronic conditions such as COPD, asthma, hypertension (HTN), diabetes, 301 idiopathic pulmonary fibrosis, sarcoidosis, and Scleroderma-associated interstitial lung 302 disease. 23, 29 303 Publicly available gene expression datasets deposited in National Center for Biotechnology 304 Information Gene Expression Omnibus (NCIB GEO, http://www.ncbi.nlm.nih.gov/geo) and 305 the European Bioinformatics Institute (EMBL-EBI, https://www.ebi.ac.uk) were used. 306 Among the selected studies, all were Affymetrix microarray platforms, and only one study 307 (GSE118761) was Illumina RNA-seq which was analyzed separately, and it was not used in 308 the microarray comparisons. Before data preprocessing, all the data were evaluated for 309 quality control (QC), and all poor quality data was removed. 30, 31 The details of the final 310 datasets are presented in Table S1 which includes 4 datasets for children groups (healthy and 311 asthmatics), 15 datasets for adults with different comorbidities (Asthmatics, COPD, 312 Idiopathic Pulmonary Fibrosis (IPH), hypertension, diabetes, Systemic sclerosis (SSc)-related 313 interstitial lung disease (ILD) and sarcoidosis), and one datasets to assess the in vitro effect 314 The raw Affymetrix data was normalized and log transformed. Microarray data (CEL files) 316 were pre-processed with Robust Multi-Array Average (RMA) technique using R software. 32 317 The probe set ID with the largest IQR of expression values were selected to represent the 318 gene. Before including a dataset in the analyses, the expression level of housekeeping genes 319 was used to evaluate whether the batch effect has a significant impact on the results. For 320 RNA-seq study, the data was pre-processed using the Bioconductor package limma-voom, 33 321 and presented as log2 counts per million (log CPM). The authors declare that they have no conflict of interest. 334 This research has been financially supported by Tissue Injury and Repair (TIR) Childhood severe acute respiratory 395 syndrome, coronavirus infections and asthma Novel coronavirus infection 397 in hospitalized infants under 1 year of age in China Epidemiology of 399 COVID-19 Among Children in China The characteristics of household transmission of COVID-19 Changes in contact patterns shape the dynamics of 405 the COVID-19 outbreak in China SARS-CoV-2 Infection in Children Aging of the immune system: how much can the adaptive 409 immune system adapt? Epigenetic regulation 411 of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy 412 stress Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, 418 China Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential 421 Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) Hypoxic regulation of 424 angiotensin-converting enzyme 2 and Mas receptor in human CD34+ cells Sex difference and smoking predisposition in patients with COVID-19 SARS-CoV-2 Cell Entry Depends 430 on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor A pneumonia outbreak associated with a new coronavirus of 433 probable bat origin Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike 436 Protein by the Transmembrane Protease TMPRSS2 Using gene expression datasets, Halwani and coworkers showed that the airways expression of these receptors is lower in children, while upregulated in smokers and COPD patients Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in 392 Figure S1 . Normalized mRNA expression levels of ACE2 and TMPRSS2 genes in PBMCs of different diseases. (A) There was no significant difference in expression levels of ACE2 and TMPRSS2 in PBMCs of chronic obstructive pulmonary disease (COPD) compared to the healthy controls. (B) Comparisons of PBMCs of asthmatic versus control showed that while level of ACE2 was significantly higher in asthmatics there was no difference in PBMCs levels of TMPRSS2. (C) There was no difference in both the levels of ACE2 and TMPRS2 in PBMCs of type 1 diabetes compared to healthy controls. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001.